Circulating endothelial-derived activated microparticle: A useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung Cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Chin Chou ^a,b,c   Tseng, Chia Cheng ^a   Hsiao, Chang Chun ^d,e   Chang, Huang Chih ^a   Chang, Li Teh ^f   Fang, Wen Feng ^a   Leu, Steve ^d   Wang, Yi Hsi ^a   Tsai, Tzu Hsien ^a   Yang, Cheng Ta ^a   Chen, Chih Hung ^a   Yip, Hon Kan ^a,d   Ho, Chi Kung ^b   Lin, Meng Chih ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f MEIHO UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; TUMOR MARKER;

ADJUVANT CHEMORADIOTHERAPY; ADRENAL METASTASIS; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; BODY MASS; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CHARLSON COMORBIDITY INDEX; DIABETES MELLITUS; DISTANT METASTASIS; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; PLATELET DERIVED APOPTOTIC MICROPARTICLE; PLATELET MICROPARTICLE; PLEURA METASTASIS; PROSPECTIVE STUDY; SMOKING; SURVIVAL PREDICTION; SURVIVAL RATE; THROMBOCYTE COUNT; TUMOR VOLUME; AGED; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SECONDARY; SEX DIFFERENCE; VASCULAR ENDOTHELIUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL-DERIVED MICROPARTICLES; DISEASE-FREE SURVIVAL; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84904613023     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/173401     Document Type: Article

References (50)

1. Jemal A., Center M. M., DeSantis C., Ward E. M., Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology Biomarkers and Prevention 2010 19 8 1893 1907 10.1158/1055-9965.EPI-10-0437 2-s2.0-77955462853
2. Ramalingam S. S., Owonikoko T. K., Khuri F. R., Lung cancer: new biological insights and recent therapeutic advances. CA Cancer Journal for Clinicians 2011 61 2 91 112 10.3322/caac.20102 2-s2.0-79955006086
3. Favaretto A. G., Pasello G., Magro C., Second and third line treatment in advanced non-small cell lung cancer. Discovery Medicine 2009 8 43 204 209 2-s2.0-77952472292
4. Marcus P. M., Bergstralh E. J., Fagerstrom R. M., Williams D. E., Fontana R., Taylor W. F., Prorok P. C., Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. Journal of the National Cancer Institute 2000 92 16 1308 1316 10.1093/jnci/92.16.1308 2-s2.0-0034674906 (Pubitemid 30660590)
5. Maione P., Rossi A., Sacco P. C., Bareschino M. A., Schettino C., Gridelli C., Advances in chemotherapy in advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 2010 11 18 2997 3007 10.1517/14656566.2010. 511615 2-s2.0-78649269172
6. Kwak E. L., Bang Y. J., Camidge D. R., Shaw A. T., Solomon B., Maki R. G., Ou S. I., Dezube B. J., Jänne P. A., Costa D. B., Varella-Garcia M., Kim W., Lynch T. J., Fidias P., Stubbs H., Engelman J. A., Sequist L. V., Tan W., Gandhi L., Mino-Kenudson M., Wei G. C., Shreeve S. M., Ratain M. J., Settleman J., Christensen J. G., Haber D. A., Wilner K., Salgia R., Shapiro G. I., Clark J. W., Iafrate A. J., Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. The New England Journal of Medicine 2010 363 18 1693 1703 10.1056/NEJMoa1006448 2-s2.0-78049425319
7. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J., Vansteenkiste J., Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine 2004 350 4 351 360 10.1056/NEJMoa031644 2-s2.0-0346238665 (Pubitemid 38101630)
8. Spiro S. C., Silvestri G. A., One hundred years of lung cancer. The American Journal of Respiratory and Critical Care Medicine 2005 172 5 523 529 10.1164/rccm.200504-531OE 2-s2.0-24144480937 (Pubitemid 41232963)
9. Stinchcombe T. E., Socinski M. A., Maintenance therapy in advanced non-small cell lung cancer: current status and future implications. Journal of Thoracic Oncology 2011 6 1 174 182 10.1097/JTO.0b013e318200f9c5 2-s2.0-78651087055
10. Veeramachaneni N. K., Feins R. H., Stephenson B. J. K., Edwards L. J., Fernandez F. G., Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America. Annals of Thoracic Surgery 2012 94 3 922 928 10.1016/j.athoracsur.2012.04.087 2-s2.0-84865242254
11. Herbst R. S., Onn A., Sandler A., Angiogenesis and lung cancer: prognostic and therapeutic implications. Journal of Clinical Oncology 2005 23 14 3243 3256 10.1200/JCO.2005.18.853 2-s2.0-19844364244 (Pubitemid 46211349)
12. Chanin T. D., Merrick D. T., Franklin W. A., Hirsch F. R., Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. Current Opinion in Pulmonary Medicine 2004 10 4 242 247 10.1097/01.mcp.0000130321.11513.13 2-s2.0-3042524939 (Pubitemid 38803114)
13. Hassanein M., Callison J. C., Callaway-Lane C., Aldrich M. C., Grogan E. L., Massion P. P., The state of molecular biomarkers for the early detection of lung cancer. Cancer Prevention Research 2012 5 8 992 1006 10.1158/1940-6207. CAPR-11-0441 2-s2.0-84866508033
14. Mostefai H. A., Andriantsitohaina R., Martínez M. C., Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiological Research 2008 57 3 311 320 2-s2.0-45849127669
15. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P. G., Freyssinet J., Tedgui A., Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 8 841 843 10.1161/01.CIR.101.8.841 2-s2.0-0033999142 (Pubitemid 30117876)
16. Martin S., Tesse A., Hugel B., Martínez M. C., Morel O., Freyssinet J., Andriantsitohaina R., Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 2004 109 13 1653 1659 10.1161/01.CIR.0000124065.31211.6E 2-s2.0-1842455359 (Pubitemid 38451723)
17. Martínez M. C., Tesse A., Zobairi F., Andriantsitohaina R., Shed membrane microparticles from circulating and vascular cells in regulating vascular function. American Journal of Physiology-Heart and Circulatory Physiology 2005 288 3 H1004 H1009 10.1152/ajpheart.00842.2004 2-s2.0-13944276772 (Pubitemid 40269999)
18. Mezentsev A., Merks R. M. H., O'Riordan E., Chen J., Mendelev N., Goligorsky M. S., Brodsky S. V., Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology 2005 289 3 H1106 H1114 10.1152/ajpheart.00265.2005 2-s2.0-23944476083 (Pubitemid 41208953)
19. Martínez M. C., Larbret F., Zobairi F., Coulombe J., Debili N., Vainchenker W., Ruat M., Freyssinet J., Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 2006 108 9 3012 3020 10.1182/blood-2006-04-019109 2-s2.0-33748556776
20. Nomura S., Ozaki Y., Ikeda Y., Function and role of microparticles in various clinical settings. Thrombosis Research 2008 123 1 8 23 10.1016/j.thromres.2008.06.006 2-s2.0-51349130861
21. Zwaal R. F. A., Schroit A. J., Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997 89 4 1121 1132 2-s2.0-0031043059 (Pubitemid 27079974)
22. Horstman L. L., Ahn Y. S., Platelet microparticles: a wide-angle perspective. Critical Reviews in Oncology/Hematology 1999 30 2 111 142 10.1016/S1040-8428(98)00044-4 2-s2.0-0032953002 (Pubitemid 29232249)
23. Nomura S., Function and clinical significance of platelet-derived microparticles. International Journal of Hematology 2001 74 4 397 404 10.1007/BF02982082 2-s2.0-0035751752 (Pubitemid 33760100)
24. Nomura S., Uehata S., Saito S., Osumi K., Ozeki Y., Kimura Y., Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thrombosis and Haemostasis 2003 89 3 506 512 2-s2.0-0037340351 (Pubitemid 36329242)
25. Joop K., Berckmans R. J., Nieuwland R., Berkhout J., Romijn F. P. H. T. M., Hack C. E., Sturk A., Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thrombosis and Haemostasis 2001 85 5 810 820 2-s2.0-0035002186 (Pubitemid 32421813)
26. Ogata N., Imaizumi M., Nomura S., Shozu A., Arichi M., Matsuoka M., Matsumura M., Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 2005 68 3 193 201 10.1016/j.diabres.2004.10.010 2-s2.0-20144372790 (Pubitemid 40775985)
27. Daniel L., Fakhouri F., Joly D., Mouthon L., Nusbaum P., Grunfeld J.-., Schifferli J., Guillevin L., Lesavre P., Halbwachs-Mecarelli L., Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney International 2006 69 8 1416 1423 10.1038/sj.ki.5000306 2-s2.0-33646128738
28. Tesselaar M. E. T., Romijn F. P. H. T. M., van der Linden I. K., Prins F. A., Bertina R. M., Osanto S., Microparticle-associated tissue factor activity: a link between cancer and thrombosis? Journal of Thrombosis and Haemostasis 2007 5 3 520 527 10.1111/j.1538-7836.2007.02369.x 2-s2.0-34247606502 (Pubitemid 46680685)
29. Nomura S., Kagawa H., Ozaki Y., Nagahama M., Yoshimura C., Fukuhara S., Relationship between platelet activation and cytokines in systemic inflammatory response syndrome patients with hematological malignancies. Thrombosis Research 1999 95 5 205 213 10.1016/S0049-3848(99)00024-9 2-s2.0-0032844816 (Pubitemid 29428152)
30. Janowska-Wieczorek A., Marquez-Curtis L. A., Wysoczynski M., Ratajczak M. Z., Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 2006 46 7 1199 1209 10.1111/j.1537-2995.2006.00871.x 2-s2.0-33746555498 (Pubitemid 44139495)
31. Kanazawa S., Nomura S., Kuwana M., Muramatsu M., Yamaguchi K., Fukuhara S., Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 2003 39 2 145 149 10.1016/S0169-5002(02) 00441-5 2-s2.0-0037311928 (Pubitemid 36173614)
32. Tseng C.-C., Wang C.-C., Chang H.-C., Levels of circulating microparticles in lung cancer patients and possible prognostic value. Disease Markers 2013 35 5 301 310 10.1155/2013/715472
33. Edge S. B., Compton C. C., The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 2010 17 6 1471 1474 10.1245/s10434-010-0985-4 2-s2.0-77954818058
34. Dey-Hazra E., Hertel B., Kirsch T., Woywodt A., Lovric S., Haller H., Haubitz M., Erdbruegger U., Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing. Vascular Health and Risk Management 2010 6 1 1125 1133 10.2147/VHRM.S13236 2-s2.0-79960955512
35. Leu S., Lu H.-I., Sun C.-K., Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia. International Journal of Cardiology 2014 170 3 394 405 10.1016/j.ijcard.2013.11.021
36. Therasse P., Arbuck S. G., Eisenhauer E. A., Wanders J., Kaplan R. S., Rubinstein L., Verweij J., Van Glabbeke M., Van Oosterom A. T., Christian M. C., Gwyther S. G., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000 92 3 205 216 10.1093/jnci/92.3.205 2-s2.0-0034594628
37. Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T.E., McFadden E. T., Carbone P. P., Toxicology and response criteria of the eastern cooperative oncology group. The American Journal of Clinical Oncology: Cancer Clinical Trials 1982 5 6 649 655 2-s2.0-0020396015 (Pubitemid 13149996)
38. Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987 40 5 373 383 10.1016/0021-9681(87) 90171-8 2-s2.0-0023092594 (Pubitemid 17055592)
39. Giusti I., D'Ascenzo S., Dolo V., Microvesicles as potential ovarian cancer biomarkers. BioMed Research International 2013 2013 12 703048 10.1155/2013/703048 2-s2.0-84874592320
40. Fleitas T., Martínez-Sales V., Vila V., Reganon E., Mesado D., Martín M., Gómez-Codina J., Montalar J., Reynés G., Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS ONE 2012 7 10 e47365 10.1371/journal.pone.0047365 2-s2.0-84867514583
41. Stewart L. A., Pignon J. P., Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal 1995 311 7010 899 909 10.1136/bmj.311.7010.899 2-s2.0-0028843552
42. Mandrekar S. J., Schild S. E., Hillman S. L., Allen K. L., Marks R. S., Mailliard J. A., Krook J. E., Maksymiuk A. W., Chansky K., Kelly K., Adjei A. A., Jett J. R., A prognostic model for advanced stage nonsmall cell lung cancer: pooled analysis of north central cancer treatment group trials. Cancer 2006 107 4 781 792 10.1002/cncr.22049 2-s2.0-33747164218 (Pubitemid 44232670)
43. Park M. J., Lee J., Hong J. Y., Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment. Cancer 2009 115 7 1518 1530 10.1002/cncr.24151
44. Berghmans T., Paesmans M., Sculier J. P., Prognostic factors in stage III non-small lung cancer: a review of conventional, metabolic and new biological variables. Therapeutic Advances in Medical Oncology 2011 3 3 127 138 10.1177/1758834011401951 2-s2.0-79960209587
45. Sequist L. V., Bell D. W., Lynch T. J., Haber D. A., Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. Journal of Clinical Oncology 2007 25 5 587 595 10.1200/JCO.2006.07. 3585 2-s2.0-33947498978 (Pubitemid 350002967)
46. Shim H. S., Lee D. H., Park E. J., Kim S. H., Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the international association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification. Archives of Pathology and Laboratory Medicine 2011 135 10 1329 1334 10.5858/arpa.2010-0493-OA 2-s2.0-80055074897
47. Baj-Krzyworzeka M., Majka M., Pratico D., Ratajczak J., Vilaire G., Kijowski J., Reca R., Janowska-Wieczorek A., Ratajczak M. Z., Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Experimental Hematology 2002 30 5 450 459 10.1016/S0301-472X(02)00791-9 2-s2.0-0036258785 (Pubitemid 34556736)
48. Kim H. K., Song K. S., Chung J., Lee K. R., Lee S., Platelet microparticles induce angiogenesis in vitro. The British Journal of Haematology 2004 124 3 376 384 10.1046/j.1365-2141.2003.04773.x 2-s2.0-0842308828 (Pubitemid 38167990)
49. Varon D., Shai E., Role of platelet-derived microparticles in angiogenesis and tumor progression. Discovery Medicine 2009 8 43 237 241 2-s2.0-77952010480
50. Ardoin S. P., Shanahan J. C., Pisetsky D. S., The role of microparticles in inflammation and thrombosis. Scandinavian Journal of Immunology 2007 66 2-3 159 165 10.1111/j.1365-3083.2007.01984.x 2-s2.0-34447297875 (Pubitemid 47063209)